Building a Compliant Content Foundation for the Future

This white paper discusses the importance of establishing a compliant content foundation for emerging biotechs as they prepare for product launches. It outlines how a strong foundation in medical, legal, and regulatory (MLR) review processes can provide a competitive edge and enhance scalability. The paper presents data indicating that by 2026, first-time biotech launches will surpass those of established companies. It details the risks associated with manual MLR processes, including compliance violations and inefficiencies, and advocates for the automation of these workflows through dedicated systems like Veeva PromoMats. The document highlights the benefits of modern claims management, including significant reductions in review cycle times and improved compliance. Additionally, it emphasizes the necessity of a standardized content taxonomy to avoid future operational disconnects. The integration of Veeva solutions is also discussed as a means to streamline content management and ensure compliance throughout the content lifecycle.